A great deal has been written about Merck’s drug Fosamax and its health and safety problems. As previously reported, there have been a number of Fosamax-related cases filed around the country. The first Fosamax trial is scheduled in federal court in New York City for August 2009. This will be the first of three bellwether cases tried in the MDL. Lawyers in our firm are working on several Fosamax cases as well, including one set for trial in Montgomery, Alabama, in the fall of 2009. Fosamax users around the country have suffered significant injuries, including osteonecrosis of the jaw, as a result of using Fosamax. Osteonecrosis of the jaw, or “ONJ,” is a disfiguring and disabling condition of the jaw bone which includes severe infection and rotting of the jaw bone. If you have questions about Fosamax, you can contact Chad Cook (Chad.Cook@BeasleyAllen.com) at our firm at 800-898-2034.

Other Related Articles

• Jury Rules For The Defendant In Second Fosamax Trial
• 24 Fosamax lawsuits will go forward
• Montgomery Fosamax trial will be one of the first in the nation
• Fosamax Lawsuit Update
• The Risks Of Taking Fosamax Appear To Be Great